Stroke Flashcards
Incidence of stroke types: Ischaemic vs Haemorrhagic.
Ischaemic: 85%
Haemorrhagic: 15%
Incidence of stroke types: Ischaemic stroke causes as percentage of all strokes
Ischaemic strokes = 85% all strokes:
- Cryptogenic 30%
- Lacunar (small vessel) 25%
- Atherosclerotic large vessel disease 20%
- Cardiogenic embolism 20%
- Other 5%
Mechanisms of ischaemic stroke:
- Embolism (50-60%) from heart or carotid arteries
- Thrombosis (30-40%) - eg. lacunar
- Hypoperfusion (5-10%) stenosis, hypotension - worst in ‘watershed’ areas
Main causes of intracerebral haemorrhage (4):
- Hypertension (75%)
- Coagulopathy (5-10%)
- liver disease, iatrogenic (antithrombotis, thrombolysis) - Amyloid angiopathy 5-10%
- Underlying vascular lesion (AVM, cavernous sinus haemangiomas) 5-10%
Risk factors for stroke - modifiable and non-modifiable:
Non- Modifiable:
- AGE
- Gender
- Hx stroke / TIA
- FHx / genetic predisposition
Modifiable:
- HTN
- AF
- Diabetes
- Dyslipidaemia
- Carotid stenosis
- Smoking
- Obesity
- Sedentary lifestyle
- Excess alcohol
- OSA
- Hyperhomocysteinaemia
Associations of TIAs:
Further TIAs
Stroke (90-day risk)
Cardiovascular events
Death
Do MRI changes rule out TIA?****CHANGED??
CHANGED???*
No, 40-50% have abnormal DWI acutely –> approx. half of these have evidence of infarction on follow up imaging.
DWI +ve TIA patients have higher risk of recurrent TIA or stroke.
They tend to have symptoms >1hr.
Definition of TIA is:
- acute loss of focal cerebral or monocular function
- symptoms last less than 24 hours
- arterial cause
[Attempts to redefine: symptoms <1hr and no evidence of acute infarction].
Radiological signs of cerebral infarction on CT:
- Hypoattenuation
(in vascular territory) - Insular ribbon sign
- Hypodensity / swelling insular cortex (MCA infarction) - Lentiform nucleus obscuration
(“blurred basal ganglia”) = MCA territory infarct - Dense MCA sign
(due to thrombus or embolus in MCA)
- Sp but not Sn for MCA occlusion. - Haemorrhage: seen as hyperintensity
Radiological signs of cerebral infarction on MRI:
T2…
DWI…
MRA….
Acute ISCHAEMIC stroke: 4 evidence-based management options:
- Stroke unit care: decreases death and dependency (46/1000 treated)
- ASA within 48hours: reduces early stroke recurrence (9/1000 treated)
- t-PA within 4.5hours of IS (improves odds od good outcome by approx. 30-50%)
- Decompressive craniectomy for malignant MCA territory infarction (reduces mortality)
Evidence for early secondary prevention with Aspirin in acute stroke comes from which trials?
- IST (International Stroke Trial)
- Chinese Aspirin Stroke Trial (CAST)
- Multicentre Acute Stroke Trial - Italy (MAST-I)
- Data approx 15yrs old
- Can prevent 9 recurrent strokes / 1000 pts treated
Trials providing evidence for reperfusion (with t-PA) therapy:
- NINDS Trial (1995): benefit out to 3hrs.
- ECASS I-III
- ATLANTIS
- EPITHET
- IST-3 (2012): included pts >80yo; showed safety to 3hrs. 3-6hrs no benefit.
Pooled results provide evidence to 3hrs from onset.
Also evidence out to 4.5hrs.
Beyond 4.5hrs: less benefit, more bleeds.
Management of ICH - few treatment options (3) - evidence:
- Surgery: NO benefit early evacuation of haematoma (STICH, Lancet 2005)
- rFVIIa: reduces haematoma expansion but NO benefit in mortality or functional outcome (still an experimental measure)
- BP lowering:
INTERACT II Trial:
- intensive lowering of blood pressure did not result in a significant reduction in the rate of the primary outcome of death or severe disability.
- An ordinal analysis of modified Rankin scores indicated improved functional outcomes with intensive lowering of blood pressure.
Evidence for decompressive craniectomy:
…….
Components of stroke prevention:
Primary prevention:
- not aspirin (overall risk of stroke neutral, as risk of bleeding)
- anticoagulation in NVAF
- BP control
- cholesterol lowering
Secondary prevention:
- antiplatelet therapy
- BP control
- cholesterol lowering
Antiplatelet therapy in secondary prevention of stroke:
- Aspirin moderately effective
- Dipyridamole or Clopidogrel - roughly 10% benefit over aspirin
- Warfarin: no benefit (possibly increased risk) unless non-valvular AF (primary & secondary prevention): warfarin decreases stroke by approx. 65% (aspirin decreases by 20% in NVAF).
MATCH Trial: no benefit with both aspirin and clopidogrel vs aspirin alone (due to bleeding)
PROFESS Trial: Assasantin vs Clopidogrel - equivalent outcomes
NOAC Trials, compared with warfarin for stroke prevention in NVAF (?Update………)
- RE-LY: Dabigatran
- similar stroke protection
- less major bleeding and ICH - ROCKET: Rivaroxaban
- similar stroke prevention
- similar major bleeding
- less ICH - ARISTOTLE: Apixaban
- better stroke prevention
- less major bleeding and ICH
BP lowering secondary prevention IS - trial……..
PROGRESS Trial…..
BP reduction is more important than agent
Statin use acute stroke…..
SPARKLE study……
Carotid endarterectomy…..
NASCET……
ACAS….
ACST….
Severe (70-99% stenosis)
NNT = 6
definite benefit within 2 weeks (out to 3 months ok, benefit lost after that)
Mod
Mild
BP managment in the acute ischaemic stroke. (discuss both thrombolysis and conservative management)
If patient is candidate for thrombolysis, agents are: labetalol or nicardipine by infusion. Need to get BP less than 185/110 pre-treatment, and post-treatment <220/120, however if concomitant HF or IHD, do not withhold anti-HTN
What are Charcot-Bouchard aneurysms?
Small (<1mm) intracerebral aneurysms in small arteries
Particularly common in lenticulostriate vessels of basal ganglia
Due to chronic changes in vessel walls due to HTN
Can lead to lacunar infarct (thrombosis), ICH (rupture), microhaemorrhage (leak)
Microhaemorrhages surrounding basal ganglia suggestive of Charcot-Bouchard aneurysms secondary to chronic hypertension.
Cf. Peripherally-located microhaemorrhages in cerebral amyloid angiopathy (cause of lobar haemorrhage).
Important complication of hypertensive intracranial haemorrhages?
Intraventricular extension (as often adjacent to ventricles) Can --> Hydrocephalus
What is Gerstmann syndrome and what is the cause?
Gerstmann syndrome, also known as angular gyrus syndrome, is a dominant hemisphere stroke syndrome consisting of 4 components:
- agraphia or dysgraphia
- acalculia or dyscalculia
- finger agnosia
- left-right disorientation
Pure Gerstmann syndrome is said to be without aphasia.